Skip to content
Clinical Trials – home
Verifiedinfo

CHU d'Estaing

France 1 place Lucie et Raymond Aubrax, 63100 Clermont Ferrand, France

  • 9 trials recruiting
  • Chronic myeloid leukaemia · Blastic plasmacytoid dendritic cell neoplasia · Crohn's disease
  • Adults and children

About Specializations

CHU d'Estaing in Clermont Ferrand, France specialises in clinical trials of conditions such as Chronic myeloid leukaemia, Blastic plasmacytoid dendritic cell neoplasia, Crohn's disease, Polycythaemia vera, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of gastroenterology, with a particular focus on Crohn's disease. This chronic inflammatory condition of the gastrointestinal tract is a key area of research, aiming to improve patient outcomes and quality of life.

  • Post-operative recurrence prevention
  • Endoscopic assessment techniques
  • Innovative therapeutic interventions

Through its research, the center is pioneering new approaches to manage and prevent the recurrence of Crohn's disease following surgical interventions, utilizing advanced endoscopic techniques to monitor disease progression.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
1 place Lucie et Raymond Aubrax63100 Clermont FerrandFrance
Recruiting now
9 trials
Conditions studied
19
Partner status
Verified

More sites in Clermont FerrandFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

12 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:TAGRAXOFUSP
  • Sponsor:French Innovative Leukemia Organization (F.I.L.O.).

Crohn's disease

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Exl01
  • Sponsor:Groupe De Recherche Sur Les Maladies Inflammatoires Digestives
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Centre Hospitalier De Versailles
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:The University Of Birmingham
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Busulfan
  • Sponsor:Institut Paoli Calmettes
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.